Brenda was told her cancer could not be treated – now her tumor has shrunk by 80 percent

Date:

Share this article:

Del denne artikel:

A new cancer treatment has delivered promising results for a 92-year-old woman who was previously considered to have no viable treatment options.

Brenda Iveson was diagnosed in 2025 with a six-centimeter tumor in her liver.

Doctors determined that neither surgery nor conventional chemotherapy was a suitable option.

According to the Press Association, as reported by LADBible, the decision was based on both the tumor’s location and her fragile health condition.

Her case was subsequently reviewed by specialists at Leeds Teaching Hospitals NHS Trust, who believed she might be a candidate for a new type of treatment.

Also read: How green tea affects your body if you drink it every day

A more precise treatment

The method, known as electrochemotherapy, combines a low dose of chemotherapy with electrical pulses.

Using robotic technology, doctors were able to place needles with a high degree of precision around the tumor.

According to Leeds Teaching Hospitals NHS Trust, the increased accuracy may make it easier to treat patients whose tumors are located in difficult-to-reach areas or cannot be treated using traditional methods.

Significant results

Following the procedure, Brenda Iveson remains under hospital supervision. Scans show that her disease is stable.

Also read: Many people mistake this pain for a common back problem

She became the first patient in the United Kingdom to receive this robot-assisted treatment.

At the same time, the tumor has shrunk by approximately 80 percent since the procedure, according to LADBible.

Sources: LADBible and Press Association.

Also read: Heeled flip flops are more popular than ever – but experts warn of potential risks

Also read: The most aggressive cancers and how to protect yourself from them

This article is made and published by Ida-Marie Palm Varbæk, who may have used AI in the preparation.

Other articles

GLP-1 drugs like Ozempic may now be an option for a group of patients long left out

The 2026 American Diabetes Association guidance opens GLP-1 therapy to a new patient group.

Your gut bacteria may spread to the people around you more easily than anyone realized

A new Nature study finds gut microbes spread between people, sometimes across continents, faster than expected.

Low vitamin C may be quietly speeding up how fast your brain ages

A study of 2,044 older adults links lower plasma vitamin C to shrinking brain volume and weaker memory-network wiring.

Why rheumatoid arthritis attacks some joints and not others: The answer starts before birth

Oxford scientists say certain finger joints may be biologically primed for the disease before you are born.

GLP-1 drugs like Ozempic may now be an option for a group of patients long left out

The 2026 American Diabetes Association guidance opens GLP-1 therapy to a new patient group.

Your gut bacteria may spread to the people around you more easily than anyone realized

A new Nature study finds gut microbes spread between people, sometimes across continents, faster than expected.

Low vitamin C may be quietly speeding up how fast your brain ages

A study of 2,044 older adults links lower plasma vitamin C to shrinking brain volume and weaker memory-network wiring.